First-in-human trial demonstrates promise of implantable cytokine factories for ovarian cancer

Encapsulated cell therapy enables localized, sustained immune activation with favorable safety profile HOUSTON, May 12, 2026 /PRNewswire/ -- Implantable cytokine factories designed to deliver immunotherapy directly at the site of disease have taken an important step toward clinical...